Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study of Niraparib With Radiotherapy for Treatment of Metastatic Invasive Carcinoma of the Cervix

NCT03644342 is registered in ClinicalTrials.gov with Michelle S Ludwig as lead sponsor.

NCT NCT03644342
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03644342 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study of Niraparib With Radiotherapy for Treatment of Metastatic Invasive Carcinoma of the Cervix
Lead sponsor
Michelle S Ludwig
Phase
Phase 1/2
Overall status
Terminated
Start date
July 15, 2019
Completion date
September 27, 2023
Enrollment
4 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic carcinoma of the cervix